- Home
- TEF vs ZBH Comparison
TEF vs ZBH Comparison
Compare TEF & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEF
- ZBH
- Stock Information
- Founded
- TEF 1924
- ZBH 1927
- Country
- TEF Spain
- ZBH United States
- Employees
- TEF N/A
- ZBH N/A
- Industry
- TEF Telecommunications Equipment
- ZBH Industrial Specialties
- Sector
- TEF Telecommunications
- ZBH Health Care
- Exchange
- TEF Nasdaq
- ZBH Nasdaq
- Market Cap
- TEF 26.1B
- ZBH 22.4B
- IPO Year
- TEF 1987
- ZBH N/A
- Fundamental
- Price
- TEF $4.89
- ZBH $112.72
- Analyst Decision
- TEF
- ZBH Buy
- Analyst Count
- TEF 0
- ZBH 22
- Target Price
- TEF N/A
- ZBH $124.15
- AVG Volume (30 Days)
- TEF 703.9K
- ZBH 1.7M
- Earning Date
- TEF 05-08-2025
- ZBH 05-01-2025
- Dividend Yield
- TEF 6.76%
- ZBH 0.85%
- EPS Growth
- TEF N/A
- ZBH N/A
- EPS
- TEF N/A
- ZBH 4.43
- Revenue
- TEF $42,773,579,059.00
- ZBH $7,678,600,000.00
- Revenue This Year
- TEF N/A
- ZBH $3.68
- Revenue Next Year
- TEF $0.91
- ZBH $4.53
- P/E Ratio
- TEF N/A
- ZBH $25.43
- Revenue Growth
- TEF 1.63
- ZBH 3.85
- 52 Week Low
- TEF $3.89
- ZBH $97.69
- 52 Week High
- TEF $4.93
- ZBH $130.89
- Technical
- Relative Strength Index (RSI)
- TEF 74.52
- ZBH 60.25
- Support Level
- TEF $4.67
- ZBH $110.85
- Resistance Level
- TEF $4.73
- ZBH $113.64
- Average True Range (ATR)
- TEF 0.05
- ZBH 2.19
- MACD
- TEF 0.00
- ZBH 0.05
- Stochastic Oscillator
- TEF 92.50
- ZBH 68.00
About TEF Telefonica SA
Telefonica operates mobile and fixed networks in Spain (where it is the incumbent telephone operator), the UK, Germany, Brazil, and other Latin American countries like Colombia, Mexico, Argentina, and Chile. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.